Recent studies have reported that lipids from neighboring adipose tissues, lipoproteins, lysophospholipids, and intracellular storage fat have the potential to maintain viability and growth of cancer cells 6,7,8,9
Key Findings Disparities in outcomes across different patient groups defined based on race, ethnicity, gender, age, socio-economic factors, and other factors are significant and can be attributed to many intersectional drivers related to healthcare awareness, access and delivery, in addition to factors related to genetics While access and delivery of care are major factors driving disparities in outcomes, a comprehensive clinical development program that addresses diversity and ranges from pre-clinical and exploratory studies through randomized confirmatory trials for safety and efficacy through to post-approval real-world studies can advance understanding of optimal patient care, expand access to care, bring earlier insights, and accelerate innovation Stakeholders in the U.S
Since a large population of motor neurons and axons remain intact at symptom onset, the role of the immune system might be to protect these remaining neurons from degeneration
Bousova I, Kostakova S, Matouskova P, Bartikova H, Szotakova B, Skalova L (2017) Monosodium glutamate-induced obesity changed the expression and activity of glutathione S-transferases in mouse heart and kidney
GSH reduces the oxidized catalytic cysteine (Cys47-SOH) of PRDX6, sustaining its peroxidase activity against lipid peroxides, like GPX4, and linking PRDX6 directly to ferroptosis resistance (Fig
